▶ 調査レポート

世界のアンプルフィルド医薬製品市場2020年-2030年:治療別(抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他)、医薬品種類別

• 英文タイトル:Ampoule Filled Pharmaceutical Products Market (Therapeutic Area: Anti-cancer, Anti-diabetics, Neurological Drugs, Cardiovascular Drugs, Analgesics, Anti-infective, Vaccines, and Others; and Drug Type: Generic Drugs and Branded Drugs) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。世界のアンプルフィルド医薬製品市場2020年-2030年:治療別(抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他)、医薬品種類別 / Ampoule Filled Pharmaceutical Products Market (Therapeutic Area: Anti-cancer, Anti-diabetics, Neurological Drugs, Cardiovascular Drugs, Analgesics, Anti-infective, Vaccines, and Others; and Drug Type: Generic Drugs and Branded Drugs) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / MRC2102A042資料のイメージです。• レポートコード:MRC2102A042
• 出版社/出版日:Transparency Market Research / 2020年12月17日
• レポート形態:英文、PDF、180ページ
• 納品方法:Eメール
• 産業分類:包装
• 販売価格(消費税別)
  Single User(1名様閲覧)¥614,270 (USD5,795)▷ お問い合わせ
  Site Licence(同一拠点内共有可)¥932,270 (USD8,795)▷ お問い合わせ
  Enterprisewide Licence(複数拠点内共有可)¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本市場調査レポートでは、世界のアンプルフィルド医薬製品市場について調査・分析し、エグゼクティブサマリー、市場イントロダクション、市場観点、新型コロナウイルス感染症の影響、市場分析、治療別(抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他)分析、医薬品種類別分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、市場構造分析、競争状況、仮定、調査手法を掲載しています。
・エグゼクティブサマリー
・市場イントロダクション
・市場観点
・新型コロナウイルス感染症の影響
・市場分析
・世界のアンプルフィルド医薬製品市場規模:治療別(抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他)
・世界のアンプルフィルド医薬製品市場規模:医薬品種類別
・世界のアンプルフィルド医薬製品市場規模:地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)
・市場構造分析
・競争状況
・仮定
・調査手法

Ampoule Filled Pharmaceutical Products Market – Scope of the Report
Transparency Market Research (TMR) started a new study on the global ampoule filled pharmaceutical products market, providing forecast for the period of 2020-2030. In the study, growth opportunity for the ampoule filled pharmaceutical products market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the ampoule filled pharmaceutical products market, untapped opportunities for manufacturers, trends and developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.

Key Questions Answered in TMR’s Ampoule Filled Pharmaceutical Products Market Report
What will be market size for ampoule filled pharmaceutical products by the end of 2030?
What will be the impact of COVID-19 on ampoule filled pharmaceutical products market?
Which region will remain most lucrative for market growth?
Which drug class holds maximum market share in the global ampoule filled pharmaceutical products market?
Who are major key players in the ampoule filled pharmaceutical products market?
Key indicators associated with the ampoule filled pharmaceutical products market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global ampoule filled pharmaceutical products market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users have been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of ampoule filled pharmaceutical products. Furthermore, forecast factors and forecast scenarios of the ampoule filled pharmaceutical products market have been covered in the report to understand future prospects of the market.

A comprehensive evaluation and forecast on the ampoule filled pharmaceutical products market are provided on the therapeutic area, drug type, and region.

Y-o-Y growth comparison, revenue comparison, and market share comparison of various market segments are provided in the report. The ampoule filled pharmaceutical products market is analyzed at both regional and country levels.

The report delivers an exhaustive assessment on the structure of the ampoule filled pharmaceutical products market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of ampoule filled pharmaceutical products manufacturers by leveraging an intensity map. It also highlights key end users for ampoule filled pharmaceutical products.

The report includes company overview of key players. Some of the key companies profiled in the ampoule filled pharmaceutical products market report include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Sun Pharmaceutical Industries Ltd, and Cadila Healthcare.

Research Methodology
A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the ampoule filled pharmaceutical products market for the study evaluation period. The TMR report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.

Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the ampoule filled pharmaceutical products market. The report has further undergone a cross-validation by in-house professionals to make the ampoule filled pharmaceutical products market report one-of-its-kind, with the highest credibility.

レポート目次

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. TMR Analysis and Recommendations

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Market Viewpoint

3.1. Global Economic Outlook

3.2. Global Pharmaceutical Market Overview

3.3. Macro-Economic Factors and Co-relation Analysis

3.4. Forecast Factors – Relevance and Impact

3.5. Value Chain Analysis

3.5.1. Exhaustive List of Active Participants

3.5.1.1. Raw Material Suppliers

3.5.1.2. Manufacturers

3.5.1.3. Distributers/End Users

3.5.2. Profitability Margins

4. Impact of COVID-19

4.1.1. Current Statistics and Probable Future Impact

4.1.2. Current Economic Projection – GDP/GVA and Probable Impact

4.1.3. Comparison of SAARs and Market Recovery, for Key Countries

4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries

4.1.5. Impact of COVID-19 on Ampoule Filled Pharmaceutical Products Market

5. Ampoule Filled Pharmaceutical Products Market Analysis

5.1. Market Value (US$ Bn) and Analysis & Forecast

5.2. Y-o-Y Growth Projections

5.3. Absolute $ Opportunity Analysis

6. Global Ampoule Filled Pharmaceutical Products Analysis and Forecast, By Therapeutic Area

6.1. Section Summary

6.2. Introduction

6.2.1. Market share and Basis Points (BPS) Analysis By Therapeutic Area

6.2.2. Y-o-Y Growth Projections By Therapeutic Area

6.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

6.3.1. Anticancer

6.3.2. Anti-diabetics

6.3.3. Neurological Drugs

6.3.4. Cardiovascular Drugs

6.3.5. Analgesics

6.3.6. Anti- infectives

6.3.7. Vaccines

6.3.8. Others

6.4. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

6.4.1. Anticancer

6.4.2. Anti-diabetics

6.4.3. Neurological Drugs

6.4.4. Cardiovascular Drugs

6.4.5. Analgesics

6.4.6. Anti- infectives

6.4.7. Vaccines

6.4.8. Others

6.5. Market Attractiveness Analysis By Therapeutic Area

7. Global Ampoule Filled Pharmaceutical Products Analysis and Forecast, By Drug Type

7.1. Section Summary

7.2. Introduction

7.2.1. Market share and Basis Points (BPS) Analysis By Drug Type

7.2.2. Y-o-Y Growth Projections By Drug Type

7.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

7.3.1. Generic Drugs

7.3.2. Branded Drugs

7.4. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

7.4.1. Generic Drugs

7.4.2. Branded Drugs

7.5. Market Attractiveness Analysis By Drug Type

8. Global Ampoule Filled Pharmaceutical Products Market Analysis and Forecast, By Region

8.1. Section Summary

8.2. Introduction

8.2.1. Market share and Basis Points (BPS) Analysis By Region

8.2.2. Y-o-Y Growth Projections By Region

8.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. Asia Pacific

8.3.5. Middle East and Africa (MEA)

8.4. Market Size (US$ Bn) Forecast 2020-2030 By Region

8.4.1. North America

8.4.2. Latin America

8.4.3. Europe

8.4.4. Asia Pacific

8.4.5. Middle East and Africa (MEA)

8.5. Market Attractiveness Analysis By Region

9. North America Ampoule Filled Pharmaceutical Products Market Analysis and Forecast

9.1. Section Summary

9.2. Introduction

9.2.1. Market share and Basis Points (BPS) Analysis By Country

9.2.2. Y-o-Y Growth Projections By Country

9.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country

9.4. Market Size (US$ Bn) Forecast 2020-2030 By Country

9.4.1. U.S.

9.4.2. Canada

9.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

9.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

9.6.1. Anticancer

9.6.2. Anti-diabetics

9.6.3. Neurological Drugs

9.6.4. Cardiovascular Drugs

9.6.5. Analgesics

9.6.6. Anti- infectives

9.6.7. Vaccines

9.6.8. Others

9.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

9.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

9.8.1. Generic Drugs

9.8.2. Branded Drugs

9.9. Prominent Trends

10. Latin America Ampoule Filled Pharmaceutical Products Market Analysis and Forecast

10.1. Section Summary

10.2. Introduction

10.2.1. Market share and Basis Points (BPS) Analysis By Country

10.2.2. Y-o-Y Growth Projections By Country

10.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country

10.4. Market Size (US$ Bn) Forecast 2020-2030 By Country

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of Latin America

10.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

10.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

10.6.1. Anticancer

10.6.2. Anti-diabetics

10.6.3. Neurological Drugs

10.6.4. Cardiovascular Drugs

10.6.5. Analgesics

10.6.6. Anti- infectives

10.6.7. Vaccines

10.6.8. Others

10.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

10.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

10.8.1. Generic Drugs

10.8.2. Branded Drugs

10.9. Prominent Trends

11. Europe Ampoule Filled Pharmaceutical Products Market Analysis and Forecast

11.1. Section Summary

11.2. Introduction

11.2.1. Market share and Basis Points (BPS) Analysis By Country

11.2.2. Y-o-Y Growth Projections By Country

11.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country

11.4. Market Size (US$ Bn) Forecast 2020-2030 By Country

11.4.1. Germany

11.4.2. Spain

11.4.3. Italy

11.4.4. France

11.4.5. U.K.

11.4.6. BENELUX

11.4.7. NORDIC

11.4.8. Russia

11.4.9. Poland

11.4.10. Rest of Europe

11.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

11.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

11.6.1. Anticancer

11.6.2. Anti-diabetics

11.6.3. Neurological Drugs

11.6.4. Cardiovascular Drugs

11.6.5. Analgesics

11.6.6. Anti- infectives

11.6.7. Vaccines

11.6.8. Others

11.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

11.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

11.8.1. Generic Drugs

11.8.2. Branded Drugs

11.9. Prominent Trends

12. Asia Pacific Ampoule Filled Pharmaceutical Products Market Analysis and Forecast

12.1. Section Summary

12.2. Introduction

12.2.1. Market share and Basis Points (BPS) Analysis By Country

12.2.2. Y-o-Y Growth Projections By Country

12.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country

12.4. Market Size (US$ Bn) Forecast 2020-2030 By Country

12.4.1. China

12.4.2. India

12.4.3. Japan

12.4.4. ASEAN

12.4.5. Australia and New Zealand

12.4.6. Rest of APAC

12.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

12.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

12.6.1. Anticancer

12.6.2. Anti-diabetics

12.6.3. Neurological Drugs

12.6.4. Cardiovascular Drugs

12.6.5. Analgesics

12.6.6. Anti- infectives

12.6.7. Vaccines

12.6.8. Others

12.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

12.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

12.8.1. Generic Drugs

12.8.2. Branded Drugs

12.9. Prominent Trends

13. Middle East and Africa Ampoule Filled Pharmaceutical Products Market Analysis and Forecast

13.1. Section Summary

13.2. Introduction

13.2.1. Market share and Basis Points (BPS) Analysis By Country

13.2.2. Y-o-Y Growth Projections By Country

13.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country

13.4. Market Size (US$ Bn) Forecast 2020-2030 By Country

13.4.1. GCC countries

13.4.2. Northern Africa

13.4.3. South Africa

13.4.4. Turkey

13.4.5. Rest of MEA

13.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area

13.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area

13.6.1. Anticancer

13.6.2. Anti-diabetics

13.6.3. Neurological Drugs

13.6.4. Cardiovascular Drugs

13.6.5. Analgesics

13.6.6. Anti- infectives

13.6.7. Vaccines

13.6.8. Others

13.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type

13.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type

13.8.1. Generic Drugs

13.8.2. Branded Drugs

13.9. Prominent Trends

14. Market Structure Analysis

14.1. Market Analysis, by Tier of Companies

14.2. Market Concentration

14.3. Market Presence Analysis

15. Competitive Landscape

15.1. Competition Dashboard

15.2. Company Market Share Analysis

15.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)

15.4. Competition Deep Dive

15.4.1.1. Pfizer Inc

15.4.1.1.1. Overview

15.4.1.1.2. Product Portfolio

15.4.1.1.3. Profitability

15.4.1.1.4. Sales Footprint

15.4.1.1.5. Competition Benchmarking

15.4.1.1.6. Strategy

15.4.1.1.6.1. Marketing Strategy

15.4.1.1.6.2. Product Strategy

15.4.1.1.6.3. Channel Strategy

15.4.1.2. GlaxoSmithKline plc

15.4.1.2.1. Overview

15.4.1.2.2. Product Portfolio

15.4.1.2.3. Profitability

15.4.1.2.4. Sales Footprint

15.4.1.2.5. Competition Benchmarking

15.4.1.2.6. Strategy

15.4.1.2.6.1. Marketing Strategy

15.4.1.2.6.2. Product Strategy

15.4.1.2.6.3. Channel Strategy

15.4.1.3. Sanofi

15.4.1.3.1. Overview

15.4.1.3.2. Product Portfolio

15.4.1.3.3. Profitability

15.4.1.3.4. Sales Footprint

15.4.1.3.5. Competition Benchmarking

15.4.1.3.6. Strategy

15.4.1.3.6.1. Marketing Strategy

15.4.1.3.6.2. Product Strategy

15.4.1.3.6.3. Channel Strategy

15.4.1.4. Roche Holding AG

15.4.1.4.1. Overview

15.4.1.4.2. Product Portfolio

15.4.1.4.3. Profitability

15.4.1.4.4. Sales Footprint

15.4.1.4.5. Competition Benchmarking

15.4.1.4.6. Strategy

15.4.1.4.6.1. Marketing Strategy

15.4.1.4.6.2. Product Strategy

15.4.1.4.6.3. Channel Strategy

15.4.1.5. Novartis AG

15.4.1.5.1. Overview

15.4.1.5.2. Product Portfolio

15.4.1.5.3. Profitability

15.4.1.5.4. Sales Footprint

15.4.1.5.5. Competition Benchmarking

15.4.1.5.6. Strategy

15.4.1.5.6.1. Marketing Strategy

15.4.1.5.6.2. Product Strategy

15.4.1.5.6.3. Channel Strategy

15.4.1.6. Allergan

15.4.1.6.1. Overview

15.4.1.6.2. Product Portfolio

15.4.1.6.3. Profitability

15.4.1.6.4. Sales Footprint

15.4.1.6.5. Competition Benchmarking

15.4.1.6.6. Strategy

15.4.1.6.6.1. Marketing Strategy

15.4.1.6.6.2. Product Strategy

15.4.1.6.6.3. Channel Strategy

15.4.1.7. Johnson & Johnson

15.4.1.7.1. Overview

15.4.1.7.2. Product Portfolio

15.4.1.7.3. Profitability

15.4.1.7.4. Sales Footprint

15.4.1.7.5. Competition Benchmarking

15.4.1.7.6. Strategy

15.4.1.7.6.1. Marketing Strategy

15.4.1.7.6.2. Product Strategy

15.4.1.7.6.3. Channel Strategy

15.4.1.8. Merck

15.4.1.8.1. Overview

15.4.1.8.2. Product Portfolio

15.4.1.8.3. Profitability

15.4.1.8.4. Sales Footprint

15.4.1.8.5. Competition Benchmarking

15.4.1.8.6. Strategy

15.4.1.8.6.1. Marketing Strategy

15.4.1.8.6.2. Product Strategy

15.4.1.8.6.3. Channel Strategy

15.4.1.9. un Pharmaceutical Industries Ltd

15.4.1.9.1. Overview

15.4.1.9.2. Product Portfolio

15.4.1.9.3. Profitability

15.4.1.9.4. Sales Footprint

15.4.1.9.5. Competition Benchmarking

15.4.1.9.6. Strategy

15.4.1.9.6.1. Marketing Strategy

15.4.1.9.6.2. Product Strategy

15.4.1.9.6.3. Channel Strategy

15.4.1.10. Cadila Healthcare

15.4.1.10.1. Overview

15.4.1.10.2. Product Portfolio

15.4.1.10.3. Profitability

15.4.1.10.4. Sales Footprint

15.4.1.10.5. Competition Benchmarking

15.4.1.10.6. Strategy

15.4.1.10.6.1. Marketing Strategy

15.4.1.10.6.2. Product Strategy

15.4.1.10.6.3. Channel Strategy

16. Assumptions and Acronyms

17. Research Methodology

List of Tables

Table 01: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 02: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 03: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region

Table 04: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 05: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 06: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 07: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 08: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 09: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 10: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 11: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 12: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 13: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 14: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 15: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 16: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area

Table 17: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 18: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country